Practice
Featured experience
GSK exclusive license agreement for HS-20089 with Hansoh Pharma
We advised GSK on the transaction
Azul $800 million secured notes offering
The senior secured notes are due 2028
Kenvue $4.37 billion IPO
The carve-out of the former Johnson & Johnson consumer health business is the largest U.S. IPO since November 2021
NBCUniversal sale of ownership in NBC Sports Washington to MSE
We are advising Comcast and NBCUniversal on the transaction
Roche $7.1 billion acquisition of Telavant and rights to RVT 3101 from Roivant
We are advising Roche on the acquisition
Ferrara Candy acquisition of Jelly Belly Candy
We are advising Ferrara on the acquisition
MSCI acquisition of Trove Research
We are advising MSCI on the acquisition
NICE acquisition of LiveVox
We are advising NICE on the acquisition
RayzeBio $358 million IPO
The stock is listed on the Nasdaq Global Market
Arm $4.87 billion IPO
The deal is the largest U.S. IPO since November 2021
Summit Materials $3.2 billion combination with Argos USA
We are advising Summit Materials on the transaction
Orogen Group investment in Brillio
We advised the Orogen Group on the investment
SSI Strategy acquisition of NDA Group
We advised SSI Strategy on the acquisition
Sale of majority stake in Engage PEO to Kohlberg & Company
We advised Engage PEO and Lightyear Capital on the transaction